You can purchase shares of X4 Pharmaceuticals (NASDAQ:XFOR) through any online brokerage.

View our list of the best stock brokerages

Other companies in X4 Pharmaceuticals’s space includes: Monopar Therapeutics Inc (NASDAQ:MNPR), Altimmune Inc (NASDAQ:ALT), Armata Pharmaceuticals Inc (AMEX:ARMP), Eupraxia Pharmaceuticals Inc (NASDAQ:EPRX) and PureTech Health PLC (NASDAQ:PRTC).

X4 Pharmaceuticals has a consensus price target of $6.14.

The stock price for X4 Pharmaceuticals (NASDAQ: XFOR) is $4.38 last updated April 1, 2026 at 5:35 PM EDT.

There are no upcoming dividends for X4 Pharmaceuticals.

X4 Pharmaceuticals does not have any upcoming earnings scheduled.

There is no upcoming split for X4 Pharmaceuticals.

X4 Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.